Skip to content

Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled Trial

Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07610499
Enrollment
40
Registered
2026-05-28
Start date
2026-10-30
Completion date
2029-05-01
Last updated
2026-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, COPE, First Line Therapy, Randomized Controlled Trial (RCT)

Brief summary

To learn if the Creating Opportunities for Personal Empowerment (COPE) intervention is feasible, acceptable, and helpful (compared to usual care) in women with breast cancer who are receiving first line treatment.

Detailed description

Primary Objectives The primary objective of this study is to assess the feasibility and acceptability of the COPE intervention, a nurse-led cognitive-behavioral skills-building intervention, in women undergoing their first line of treatment for breast cancer. * The primary endpoint of feasibility will be evaluated by the percentage of participants in the intervention arm who completes at least five of the seven intervention sessions. If at least 70% of the intervention group participants complete five or more intervention sessions, the COPE intervention will be deemed feasible in women undergoing their first line of treatment for breast cancer. * The primary endpoint of acceptability will be evaluated by an investigator-developed instrument, the Acceptability of COPE in Breast Cancer Intervention Survey, The COPE intervention will be evaluated as acceptable if ≥50% of participants report that the intervention increased their ability to cope with their breast cancer diagnosis in their response to Question 1, "The COPE sessions affected my ability to cope with my breast cancer diagnosis in the following way: A) Increased my ability to cope with my breast cancer diagnosis: B) Decreased my ability to cope with my breast cancer diagnosis; or C) No change in my ability to cope with my breast cancer diagnosis."

Interventions

OTHERStandard of Care (SOC)

Given by Questionnaires

OTHERIntervention sessions

7 week sessions

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligibility Criteria * Female * Age 18 years and older * Diagnosed with stage I-III breast cancer * Receiving first line treatment for breast cancer * Receiving treatment at MD Anderson * Able to read, speak, and consent in English * Able to understand and be willing to sign a written informed consent document * Able to complete the study questionnaires and intervention sessions

Exclusion criteria

* Diagnosed with multiple tumor types * Diagnosed with stage IV breast cancer * Unable to provide consent, such as cognitively impaired individuals * Has a preexisting psychiatric diagnosis (e.g., bipolar depression)

Design outcomes

Primary

MeasureTime frame
Patient-Reported Outcomes Measurement QuestionnaireThrough study completion; an average of 1 year

Countries

United States

Contacts

CONTACTEileen D Hacker, MD
ehacker@mdanderson.org713-563-4004
PRINCIPAL_INVESTIGATOREileen D Hacker, MD

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026